Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilbert Lefèvre

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Malaria Journal|October 13, 2009
Understanding the pharmacokinetics of CoartemAbdoulaye Djimdé, Gilbert Lefèvre
Journal of Pharmaceutical Sciences|May 24, 2016
Pharmacokinetic Modeling to Simulate the Concentration-Time Profiles After Dermal Application of Rivastigmine PatchSachiko Nozaki, Masayuki Yamaguchi, Gilbert Lefèvre
Annals of the New York Academy of Sciences|March 26, 2011
Novartis Malaria Initiative: best practice example of pharmaceutical industry's engagement in the fight against malariaGilbert Lefèvre, Anne Claire Marrast, Heiner Grueninger
The American Journal of Tropical Medicine and Hygiene|July 26, 2002
Comparison of the cardiac effects of the antimalarials co-artemether and halofantrine in healthy participantsMargaretha Bindschedler, Gilbert Lefèvre, Peter Degen, et al.
Drugs & Aging|September 30, 2016
Effects of Renal Impairment on Steady-State Plasma Concentrations of Rivastigmine: A Population Pharmacokinetic Analysis of Capsule and Patch Formulations in Patients with Alzheimer's DiseaseGilbert Lefèvre, Francesca Callegari, Sandro Gsteiger, et al.
Neurology|July 31, 2007
Pharmacokinetic rationale for the rivastigmine patchJeffrey Cummings, Gilbert Lefèvre, Gary Small, et al.
British Journal of Clinical Pharmacology|November 26, 2002
Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjectsGilbert Lefèvre, Polly Carpenter, Claire Souppart, et al.
Current Medical Research and Opinion|November 16, 2007
Rivastigmine exposure provided by a transdermal patch versus capsulesFrançois Mercier, Gilbert Lefèvre, Hsun-Lun Aaron Huang, et al.
Clinical Drug Investigation|May 16, 2008
Steady-state pharmacokinetics of rivastigmine in patients with mild to moderate Alzheimer's disease not affected by co-administration of memantine: an open-label, crossover, single-centre studyJoshua Shua-Haim, Juanita Smith, Franck Picard, et al.
Antimicrobial Agents and Chemotherapy|April 8, 2015
Open-label, single-dose, parallel-group study in healthy volunteers to determine the drug-drug interaction potential between KAE609 (cipargamin) and piperaquineDaniel S Stein, Jay Prakash Jain, Michael Kangas, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Malaria Journal|October 13, 2009
Understanding the pharmacokinetics of CoartemAbdoulaye Djimdé, Gilbert Lefèvre
Journal of Pharmaceutical Sciences|May 24, 2016
Pharmacokinetic Modeling to Simulate the Concentration-Time Profiles After Dermal Application of Rivastigmine PatchSachiko Nozaki, Masayuki Yamaguchi, Gilbert Lefèvre
Annals of the New York Academy of Sciences|March 26, 2011
Novartis Malaria Initiative: best practice example of pharmaceutical industry's engagement in the fight against malariaGilbert Lefèvre, Anne Claire Marrast, Heiner Grueninger
The American Journal of Tropical Medicine and Hygiene|July 26, 2002
Comparison of the cardiac effects of the antimalarials co-artemether and halofantrine in healthy participantsMargaretha Bindschedler, Gilbert Lefèvre, Peter Degen, et al.
Drugs & Aging|September 30, 2016
Effects of Renal Impairment on Steady-State Plasma Concentrations of Rivastigmine: A Population Pharmacokinetic Analysis of Capsule and Patch Formulations in Patients with Alzheimer's DiseaseGilbert Lefèvre, Francesca Callegari, Sandro Gsteiger, et al.
Neurology|July 31, 2007
Pharmacokinetic rationale for the rivastigmine patchJeffrey Cummings, Gilbert Lefèvre, Gary Small, et al.
British Journal of Clinical Pharmacology|November 26, 2002
Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjectsGilbert Lefèvre, Polly Carpenter, Claire Souppart, et al.
Current Medical Research and Opinion|November 16, 2007
Rivastigmine exposure provided by a transdermal patch versus capsulesFrançois Mercier, Gilbert Lefèvre, Hsun-Lun Aaron Huang, et al.
Clinical Drug Investigation|May 16, 2008
Steady-state pharmacokinetics of rivastigmine in patients with mild to moderate Alzheimer's disease not affected by co-administration of memantine: an open-label, crossover, single-centre studyJoshua Shua-Haim, Juanita Smith, Franck Picard, et al.
Antimicrobial Agents and Chemotherapy|April 8, 2015
Open-label, single-dose, parallel-group study in healthy volunteers to determine the drug-drug interaction potential between KAE609 (cipargamin) and piperaquineDaniel S Stein, Jay Prakash Jain, Michael Kangas, et al.
Pageof 3